The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Nanobiotix (Inst)
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol Myers Squibb Foundation; Celgene; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Novartis; Seagen
Travel, Accommodations, Expenses - Nanobiotix
Phase I study of functionalized hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.
 
Christophe Le Tourneau
No Relationships to Disclose
 
Valentin Calugaru
Honoraria - Nanobiotix (Inst)
Consulting or Advisory Role - Nanobiotix (Inst)
Travel, Accommodations, Expenses - Nanobiotix (Inst)
 
Zoltan Takacsi-Nagy
Honoraria - Nanobiotix (Inst)
Consulting or Advisory Role - Nanobiotix
 
Xavier Liem
Honoraria - Nanobiotix (Inst)
Consulting or Advisory Role - Nanobiotix
 
Zsuzsanna Papai
Honoraria - Nanobiotix (Inst)
 
Jacek Fijuth
Honoraria - Nanobiotix (Inst)
 
Victor Moreno
Employment - START
Consulting or Advisory Role - Basilea; Bayer; BMS; Janssen Oncology; Merck; Roche
Speakers' Bureau - Bayer
Research Funding - Abbvie (Inst); ACEA Biosciences (Inst); Adaptimmune (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); E-therapeutics (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Menarini (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PsiOxus Therapeutics (Inst); Puma Biotechnology (Inst); Regeneron (Inst); RigonTEC (Inst); Roche (Inst); Sanofi (Inst); Sierra Oncology (Inst); Synthon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tesaro (Inst); Transgene (Inst)
Expert Testimony - Medscape/Bayer; Nanobiotix
Travel, Accommodations, Expenses - Sanofi/Regeneron
Other Relationship - BMS
 
Jordi Giralt
No Relationships to Disclose
 
Sébastien Salas
Honoraria - Nanobiotix (Inst)
 
Gilles Poissonnet
No Relationships to Disclose
 
Emiliano Calvo
Honoraria - Nanobiotix (Inst)
 
Bernard Doger
Honoraria - Nanobiotix (Inst)
 
Olivier Choussy
No Relationships to Disclose
 
Xavier Mirabel
Honoraria - Nanobiotix (Inst)
 
Samar Krhili
Honoraria - Nanobiotix (Inst)
 
Katell Bernois
Employment - Nanobiotix
 
Nicolas Fakhry
No Relationships to Disclose
 
Stéphanie Wong-Hee-Kam
No Relationships to Disclose
 
Edith Borcoman
No Relationships to Disclose
 
Caroline Hoffmann
Honoraria - Nanobiotix (Inst)
Consulting or Advisory Role - Nanobiotix (Inst)
Travel, Accommodations, Expenses - Nanobiotix (Inst)